Novartis Ag (NVS) EPS (Diluted) (2009 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) EPS (Diluted) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -3.06 |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 7.27 |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | 1.39 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 |
| Mar 31, 2026 | 2.31 |
| Dec 31, 2025 | 5.24 |
| Sep 30, 2025 | 2.19 |
| Jun 30, 2025 | 1.99 |
| Mar 31, 2025 | 2.56 |
| Dec 31, 2024 | 5.70 |
| Sep 30, 2024 | 1.71 |
| Jun 30, 2024 | 1.55 |
| Mar 31, 2024 | 1.71 |
| Dec 31, 2023 | 6.41 |
| Sep 30, 2023 | 0.84 |
| Jun 30, 2023 | 1.05 |
| Mar 31, 2023 | 1.38 |
| Dec 31, 2022 | 3.29 |
| Sep 30, 2022 | 0.92 |
| Jun 30, 2022 | 0.75 |
| Mar 31, 2022 | 1.38 |
| Dec 31, 2021 | 7.94 |
| Sep 30, 2021 | 1.61 |